Physician profile
Sharon B Mass
NPI 1043279292
$7,028.07
in general payments reported to CMS, 2019-2025
9 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,255 · 2020: $2,124 · 2021: $963 · 2022: $1,550 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $90.00 · Food and Beverage: $45.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $90.00 |
| Food and Beverage | $45.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $6,737.00 | 2019-2022 | |
| Millicent US INC | $90.00 | 2025 | |
| Amag Pharmaceuticals, INC. | $56.38 | 2019 | |
| Exeltis, USA INC. | $53.93 | 2019-2021 | |
| Pfizer INC. | $30.95 | 2025 | |
| Avion Pharmaceuticals | $26.15 | 2019-2020 | |
| Hologic Sales and Service, LLC | $18.66 | 2019 | |
| Coopersurgical, INC. | $15.00 | 2025 | Paragard T 380a |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Mass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.